Long-term follow-up of women with atypical squamous cells of undetermined significance (ASCUS)
โ Scribed by Robert E. Emerson; Anna Puzanov; Carolyn Brunnemer; Cheryl Younger; Harvey Cramer
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 59 KB
- Volume
- 27
- Category
- Article
- ISSN
- 8755-1039
- DOI
- 10.1002/dc.10157
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The Bethesda System recommends that the diagnosis of "atypical squamous cells of undetermined significance" (ASCUS) be qualified when possible to indicate whether a reactive process, or a squamous intraepithelial lesion (SIL), is favored. In order to evaluate the utility of this recommendation, 308
In the first year since the institution of the Bethesda system at UCDMC, 549/7,388 (7.43%) Papanicolaou (Pap) smears were diagnosed as having an epithelial abnormality. One hundred ninety-three of the 549 (35. I %) of the abnormal smears received an ASCUS diagnosis, representing 2.61 % of the total
The diagnosis of ASCUS (atypical squamous cells of undetermined significance) was introduced in the 1988 Bethesda System for reporting cervical/vaginal cytologic findings. Outcome and appropriate management of patients with this diagnosis is not presently established. Criteria defining ASCUS are nuc
## Background: The authors have noted that in cervical cytology specimens from perimenopausal and postmenopausal women, the diagnosis of atypical squamous cells of undetermined significance (asc-us), as defined in the bethesda system, is often not associated with a clinically evident lesion on foll